Media Summary: Register to upcoming events everythingals.org/events Participate in our Robert Kalb, MD, is the Joan and Paul Rubschlager Professor of Neurology, chief of Neuromuscular Disease and director of the ... Using advanced DNA sequencing methods, researchers have identified a new

Mark Kiel On Als Genetics - Detailed Analysis & Overview

Register to upcoming events everythingals.org/events Participate in our Robert Kalb, MD, is the Joan and Paul Rubschlager Professor of Neurology, chief of Neuromuscular Disease and director of the ... Using advanced DNA sequencing methods, researchers have identified a new For this Expert Talk, we were honored to host Jennifer Roggenbuck, MS, CGC, a licensed In this Keck Graduate Institute (KGI) Industry Speaker Series Presentation, Genomenon founder and Chief Science Officer, Dr. Please watch our ASK ME educational webinar, “

This week Jeremy digs into what we know about The primary goal of this webinar is to give a complete picture of the industry environment in terms of AI usage in drug discovery, ... Research is increasingly demonstrating that EverythingALS trial uses advanced computation technology and speech, audio and video data to find

Photo Gallery

Mark Kiel on ALS Genetics
Genomenon | Comprehensive ALS Genomic Landscape | Implications for Drug Discovery and Development
ALS 101 (Part 2): Genetics and Familial ALS
The Discovery of a New ALS Risk Gene KANK1: what it tells us about the cause of ALS
Metabolic Rewiring in Models of Familial ALS
Genetic Factors of ALS | ALS Tool Kit
A new gene associated with ALS
Fighting ALS at the Genetic Level: Real World Results for Tofersen
Genetics and ALS: What New Discoveries Mean for You and Your Family with Jennifer Roggenbuck MS, CGC
A Start-Up Story: My Life as a Recovering Academic | KGI Industry Speaker Series | Dr. Mark Kiel
FDA approves ALS treatment for patients with genetic disease
The Comprehensive A I  Driven Genomic Landscape for ALS   Implications for Drug Discovery and Develo
Sponsored
Sponsored
View Detailed Profile
Mark Kiel on ALS Genetics

Mark Kiel on ALS Genetics

In this episode we are exploring the

Genomenon | Comprehensive ALS Genomic Landscape | Implications for Drug Discovery and Development

Genomenon | Comprehensive ALS Genomic Landscape | Implications for Drug Discovery and Development

Amyotrophic Lateral Sclerosis

Sponsored
ALS 101 (Part 2): Genetics and Familial ALS

ALS 101 (Part 2): Genetics and Familial ALS

The

The Discovery of a New ALS Risk Gene KANK1: what it tells us about the cause of ALS

The Discovery of a New ALS Risk Gene KANK1: what it tells us about the cause of ALS

Register to upcoming events everythingals.org/events Participate in our

Metabolic Rewiring in Models of Familial ALS

Metabolic Rewiring in Models of Familial ALS

Robert Kalb, MD, is the Joan and Paul Rubschlager Professor of Neurology, chief of Neuromuscular Disease and director of the ...

Sponsored
Genetic Factors of ALS | ALS Tool Kit

Genetic Factors of ALS | ALS Tool Kit

Learn about

A new gene associated with ALS

A new gene associated with ALS

Using advanced DNA sequencing methods, researchers have identified a new

Fighting ALS at the Genetic Level: Real World Results for Tofersen

Fighting ALS at the Genetic Level: Real World Results for Tofersen

Amyotrophic lateral sclerosis

Genetics and ALS: What New Discoveries Mean for You and Your Family with Jennifer Roggenbuck MS, CGC

Genetics and ALS: What New Discoveries Mean for You and Your Family with Jennifer Roggenbuck MS, CGC

For this Expert Talk, we were honored to host Jennifer Roggenbuck, MS, CGC, a licensed

A Start-Up Story: My Life as a Recovering Academic | KGI Industry Speaker Series | Dr. Mark Kiel

A Start-Up Story: My Life as a Recovering Academic | KGI Industry Speaker Series | Dr. Mark Kiel

In this Keck Graduate Institute (KGI) Industry Speaker Series Presentation, Genomenon founder and Chief Science Officer, Dr.

FDA approves ALS treatment for patients with genetic disease

FDA approves ALS treatment for patients with genetic disease

The FDA has fast-tracked a new

The Comprehensive A I  Driven Genomic Landscape for ALS   Implications for Drug Discovery and Develo

The Comprehensive A I Driven Genomic Landscape for ALS Implications for Drug Discovery and Develo

Presented By:

John Landers, PhD: Mutations in the profilin 1 gene cause familial ALS

John Landers, PhD: Mutations in the profilin 1 gene cause familial ALS

A new

ASK ME - Genetic Testing and Familial ALS

ASK ME - Genetic Testing and Familial ALS

Please watch our ASK ME educational webinar, “

The Genetics of ALS

The Genetics of ALS

This week Jeremy digs into what we know about

03 Dr. Mark Kiel

03 Dr. Mark Kiel

The primary goal of this webinar is to give a complete picture of the industry environment in terms of AI usage in drug discovery, ...

Could gene editing correct genetic mutations linked to ALS?

Could gene editing correct genetic mutations linked to ALS?

Research is increasingly demonstrating that

ALS Canada webinar: Genetics & ALS

ALS Canada webinar: Genetics & ALS

Join

Genomics & the Genetics of ALS with Dr. Matthew Harms, MD of Columbia

Genomics & the Genetics of ALS with Dr. Matthew Harms, MD of Columbia

EverythingALS trial uses advanced computation technology and speech, audio and video data to find

Is ALS Hereditary? | Norton Neuroscience Institute

Is ALS Hereditary? | Norton Neuroscience Institute

Mark